MX2022009572A - Composiciones de pirrolo[2,3-b]piridina-3-carboxamida y métodos para mejorar la pérdida de audición. - Google Patents

Composiciones de pirrolo[2,3-b]piridina-3-carboxamida y métodos para mejorar la pérdida de audición.

Info

Publication number
MX2022009572A
MX2022009572A MX2022009572A MX2022009572A MX2022009572A MX 2022009572 A MX2022009572 A MX 2022009572A MX 2022009572 A MX2022009572 A MX 2022009572A MX 2022009572 A MX2022009572 A MX 2022009572A MX 2022009572 A MX2022009572 A MX 2022009572A
Authority
MX
Mexico
Prior art keywords
pyrrolo
pyridine
hearing loss
methods
ameliorating hearing
Prior art date
Application number
MX2022009572A
Other languages
English (en)
Spanish (es)
Inventor
John David Ginn
Rui Liang
Ksenia Gnedeva
A James Hudspeth
Nathaniel Kastan
Peter T Meinke
David John Huggins
Nigel John Liverton
Leigh Ashley Baxt
Robert Walter Myers
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Publication of MX2022009572A publication Critical patent/MX2022009572A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX2022009572A 2020-02-05 2021-02-05 Composiciones de pirrolo[2,3-b]piridina-3-carboxamida y métodos para mejorar la pérdida de audición. MX2022009572A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062970425P 2020-02-05 2020-02-05
PCT/US2021/016848 WO2021158936A1 (en) 2020-02-05 2021-02-05 Pyrrolo [2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss

Publications (1)

Publication Number Publication Date
MX2022009572A true MX2022009572A (es) 2022-12-13

Family

ID=77199407

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022009572A MX2022009572A (es) 2020-02-05 2021-02-05 Composiciones de pirrolo[2,3-b]piridina-3-carboxamida y métodos para mejorar la pérdida de audición.

Country Status (8)

Country Link
EP (1) EP4100008B1 (https=)
JP (1) JP7678595B2 (https=)
CN (1) CN115515579B (https=)
AU (1) AU2021215925B2 (https=)
CA (1) CA3170121A1 (https=)
ES (1) ES3025983T3 (https=)
MX (1) MX2022009572A (https=)
WO (1) WO2021158936A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023015156A1 (en) * 2021-08-02 2023-02-09 Hudspeth A James Pyrrolopyridine-3- and 4-carboxamide compositions and methods for cellular proliferation
WO2024211621A1 (en) * 2023-04-04 2024-10-10 Children's Hospital Los Angeles Lats kinase inhibitor to treat retinal degeneration

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2888848B1 (fr) * 2005-07-22 2007-09-28 Sanofi Aventis Sa Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique
WO2007067537A1 (en) * 2005-12-07 2007-06-14 Osi Pharmaceuticals, Inc. Pyrrolopyridine kinase inhibiting compounds
PE20121126A1 (es) * 2006-12-21 2012-08-24 Plexxikon Inc Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa
TWI667233B (zh) * 2013-12-19 2019-08-01 德商拜耳製藥公司 新穎吲唑羧醯胺,其製備方法、含彼等之醫藥製劑及其製造醫藥之用途
GB201602854D0 (en) * 2016-02-18 2016-04-06 Mission Therapeutics Ltd Novel compounds
JOP20190257A1 (ar) 2017-04-28 2019-10-28 Novartis Ag مركبات أريل غير متجانسة ثنائية الحلقة مندمجة 6-6 واستخدامها كمثبطات lats

Also Published As

Publication number Publication date
US20230137893A1 (en) 2023-05-04
WO2021158936A1 (en) 2021-08-12
AU2021215925A1 (en) 2022-09-08
EP4100008B1 (en) 2025-04-02
JP7678595B2 (ja) 2025-05-16
CA3170121A1 (en) 2021-08-12
EP4100008A4 (en) 2024-02-07
JP2023512823A (ja) 2023-03-29
AU2021215925B2 (en) 2026-04-09
EP4100008A1 (en) 2022-12-14
ES3025983T3 (en) 2025-06-10
CN115515579A (zh) 2022-12-23
CN115515579B (zh) 2025-09-30

Similar Documents

Publication Publication Date Title
MX2010001218A (es) Metodos y composiciones para tratamiento contra esquizofrenia mediante uso de terapia combinada de agentes antipsicoticos.
TW200736260A (en) Inhibitors of Akt activity
CA2603830A1 (en) PYRIDINE [2,3-B] PYRAZINONES
MXPA06001134A (es) Inhibidores de la actividad de la proteina cinasa b.
TNSN08059A1 (en) Novel crystalline form of a pyridazino [4,5-b] indole derivative
MX2022009572A (es) Composiciones de pirrolo[2,3-b]piridina-3-carboxamida y métodos para mejorar la pérdida de audición.
ZA202103099B (en) 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-one derivatives as hpk1 inhibitors for the treatment of cancer
NO20081133L (no) Tieno[2,3-B]-pyridin-5-karbonitriler som protein kinase inhibitorer
TN2019000110A1 (en) Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors
GEP20247611B (en) [1,2,4]triazolo[1,5-c]quinazolin-5-amines
WO2006065280A3 (en) Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
ME01592B (me) Fuzionisani derivati tiazola kao inhibitori kinaze
UA89968C2 (uk) Похідні піроло[3,2-d]-піримідин-4-ону та їх застосування у терапії
MY130736A (en) Imidazo(4,5-c) pyridin-4-one derivatives
WO2008036374A3 (en) Allogeneic stem cell transplants in non-conditioned recipients
MX2021014674A (es) Pirrolo [2,3-b] piridina sustituida y derivados de pirazolo [3,4-b] piridina como inhibidores de proteinas quinasas.
NZ508838A (en) Heterocyclic compounds as inhibitors of rotamase enzymes
WO2006113498A3 (en) 2-amino-quinaz0lin-5-ones as hsp90 inhibitors useful in treating proliferation diseases
WO2006098961A3 (en) Fused thieno [2, 3-b] pyridine and thiazolo [5, 4-b] pyridine compounds for inhibiting ksp kinesin activity
PH12022550124A1 (en) Enzyme inhibitors
PL372409A1 (en) Novel alkoxypyridine-derivatives
AU2006287480A8 (en) Bicyclic derivatives as modulators of voltage gated ion channels
MXPA05011785A (es) Moduladores positivos de receptores de acetilcolina nicotinicos.
TW200716110A (en) Inhibitors of AKT activity
CA2505990A1 (en) Palonosetron for the treatment of chemotherapy-induced emesis